RESUMO
ETHNOPHARMACOLOGICAL RELEVANCE: Autoimmune Thyroiditis (AIT) is a common refractory autoimmune disease of the endocrine system that may eventually lead to complete loss of thyroid function, with subsequent severe effects on the metabolism. Because of the deficiency in current clinical management of AIT, the need for alternative therapies is highlighted. With its multi-component and multi-target characteristics, Chinese medicine has good potential as an alternative therapy for AIT. AIM OF THE STUDY: The aim of this study was to systematically summarize the clinical efficacy and safety evaluation of TCM and its active ingredients in the treatment and regulation of AIT. Additionally, we provide an in-depth discussion of the relevant mechanisms and molecular targets to understand the protective effects of traditional Chinese medicine on AIT and explore new ideas for clinical treatment. MATERIALS AND METHODS: The literature related to "Hashimoto", "autoimmune thyroiditis", "traditional Chinese medicine," and "Chinese herbal medicine" was systematically summarized and reviewed from Web of Science Core Collection, PubMed, CNKI, and other databases. Domestic and international literature were analyzed, compared, and reviewed. RESULTS: An increasing number of studies have demonstrated that herbal medicines can intervene in immunomodulation, with pharmacological effects such as antibody lowering, anti-inflammatory, anti-apoptotic thyroid follicular cells, regulation of intestinal flora, and regulation of estrogen and progesterone levels. The signaling pathways and molecular targets of the immunomodulatory effects of Chinese herbal medicine for AIT may include Fas/FasL, Caspase, BCL-2, and TLRs/MyD88/NF-κB et al. CONCLUSIONS: The use of Chinese herbs in the treatment and management of AIT is clinically experienced, satisfactory, and safe. Future studies may evaluate the influence of herbal medicines on the occurrence and development of AIT by modulating the interaction between immune factors and conventional signaling pathways.
Assuntos
Medicamentos de Ervas Chinesas , Plantas Medicinais , Tireoidite Autoimune , Humanos , Medicina Tradicional Chinesa/efeitos adversos , Tireoidite Autoimune/tratamento farmacológico , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/etiologia , Medicamentos de Ervas Chinesas/farmacologia , Medicamentos de Ervas Chinesas/uso terapêutico , Resultado do TratamentoRESUMO
BACKGROUND: Results of modern research show a relationship between emotional stress and the occurrence of autoimmune diseases as a comorbidity. The authors use EMDR therapy (Eye Movement Desensitization and Reprocessing) to treat trauma disorders. They wondered whether and to what extent this treatment also affects autoimmune processes. METHOD: Parallel to the trauma-focused psychotherapy with EMDR, the thyroid hormone substitution dose was documented in patients with active Hashimoto's autoimmune thyroiditis requiring substitution. Hashimoto's autoimmune thyroiditis had already been diagnosed by a specialist and drug treatment had been initiated before starting outpatient psychotherapy. RESULTS AND CONCLUSION: So far in five cases a decrease in autoimmune activity and a stability of the results in the follow-up between six months and one year could be observed. It is now necessary to examine whether these results can be confirmed in a larger number of patients and a diversity of therapists and whether these observations can be transferred to other somatic comorbidities.
Assuntos
Doenças Autoimunes , Dessensibilização e Reprocessamento através dos Movimentos Oculares , Doença de Hashimoto , Tireoidite Autoimune , Humanos , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/terapia , Doença de Hashimoto/epidemiologia , Doença de Hashimoto/terapia , ComorbidadeRESUMO
Iodine deficiency is still the main cause of preventable thyroid disorders, worldwide. To optimize iodine intake, programs of voluntary or mandatory iodization of salt have been implemented in several iodine-deficient countries and iodine sufficiency has been achieved in many. Despite the clear beneficial effects on thyroid health, some concerns have been raised on the presumed detriment of iodine prophylaxis on thyroid autoimmunity. Very recent studies aimed at evaluating the long-term consequences of iodine supplementation on thyroid autoimmunity and related dysfunction, have clearly demonstrated that the early post-iodization increase in thyroid antibody positivity is largely transient and not clinically relevant, since the prevalence of overt thyroid dysfunction has remained reassuring low over two decades. The recommended iodine intake is therefore safe with regard to thyroid autoimmunity, the benefits largely outweighing the risks in a population with a stable median iodine concentration not exceeding 300 µg/L. Thus, a possible increase in thyroid autoimmunity should not represent a limitation to promoting iodine supplementation in the general population, also taking into account the steady rise in prevalence of autoimmune disorders which has occurred in the last few decades because of environmental factors other than iodine.
Assuntos
Iodo/efeitos adversos , Iodo/deficiência , Tireoidite Autoimune/epidemiologia , Animais , Dieta , Humanos , Estado Nutricional , Prevalência , RiscoRESUMO
The essential biological action of vitamin D is regulation of calcium and phosphorus metabolism and preserving bone health. In recent years there have been reports about the extraskeletal actions of vitamin D and its role in the regulation of immune system. Vitamin D supplementation appears to reduce the incidence of cardiovascular diseases, cancer, and infections and be able to reduce all-cause mortality. Deficiency of vitamin D has been found to correlate with the increased incidence of autoimmune diseases, including type 1 diabetes mellitus, rheumatoid arthritis, systemic lupus erythematosus, multiple sclerosis. Autoimmune thyroid diseases (AITD), including Graves' disease, Hashimoto's thyroiditis are relatively common autoimmune disorders affecting more than 5% of general population. It has been shown that vitamin D receptors (VDR) and 1-alpha hydroxylase are expressed in papillary thyroid cancer and normal thyroid tissue, suggesting local synthesis of 1,25(OH)2D in the thyroid. While VDR gene polymorphism has been found in much research to be associated with AITDs, very few studies have examined the impact of vitamin D deficiency on the incidence of AITDs in humans with conflicting results. This review focuses on the association between vitamin D and autoimmune thyroid diseases and summarizes the results of vitamin D supplementation studies in patients with AITD.
Assuntos
Doença de Graves/metabolismo , Doença de Hashimoto/metabolismo , Tireoidite Autoimune/metabolismo , Deficiência de Vitamina D/metabolismo , Vitamina D/metabolismo , Doença de Graves/tratamento farmacológico , Doença de Graves/epidemiologia , Doença de Hashimoto/tratamento farmacológico , Doença de Hashimoto/epidemiologia , Humanos , Receptores de Calcitriol/metabolismo , Tireoidite Autoimune/tratamento farmacológico , Tireoidite Autoimune/epidemiologia , Vitamina D/análogos & derivados , Vitamina D/uso terapêutico , Deficiência de Vitamina D/epidemiologia , Vitaminas/uso terapêuticoRESUMO
Many papers evaluated the effect of the environmental, or occupational endocrine disruptors (ED), on the thyroid gland, that can lead to thyroid autoimmunity. A higher prevalence of autoimmune thyroid diseases (AITD) was observed in people living in polluted areas near to petrochemical plants, and in petrochemical workers, but also in area contaminated with organochlorine pesticides, or with polychlorinated biphenyls, or near aluminum foundries. The exposure to Hg in chloralkali workers, or in swordfish consumers has been also found to increase AITD prevalence. Vanadium has been shown to increase the inflammatory response of thyrocytes. A beneficial effect of omega-3 fatty acids, and of myo-inositol and selenomethionine have been shown to counteract the appearance of AITD in subjects exposed to environmental or occupational ED. More large studies are needed to investigate the potential roles of ED in the induction of AITD, and of agents or habits that are able to prevent them.
Assuntos
Autoimunidade/efeitos dos fármacos , Disruptores Endócrinos/farmacologia , Glândula Tireoide/efeitos dos fármacos , Glândula Tireoide/imunologia , Tireoidite Autoimune/etiologia , Disruptores Endócrinos/toxicidade , Exposição Ambiental/efeitos adversos , Exposição Ambiental/prevenção & controle , Ácidos Graxos Ômega-3/uso terapêutico , Humanos , Inositol/uso terapêutico , Exposição Ocupacional/efeitos adversos , Exposição Ocupacional/prevenção & controle , Fatores de Risco , Selenometionina/uso terapêutico , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/prevenção & controle , Vanádio/farmacologiaRESUMO
Autoimmune thyroiditis (AIT) is characterised by infiltration of lymphocytes and destruction of thyroid gland. It results from the interaction of genetic predisposition and environmental triggers. Among environmental factors some infections, medications and inadequate micronutrients supply like selenium (Se) deficiency are believed to play a role. AIM: The aim of our study was to assess the serum selenium concentration in patients with AIT and healthy volunteers in the Polish population living in the Poznan district, and to compare our results with similar trials conducted on other European AIT groups. MATERIALS AND METHODS: Fifty three patients with AIT were included in the study. Elevated thyroperoxidase antibodies and/or thyroglobulin antibodies concentration and abnormalities typical for AIT in the thyroid ultrasound were the inclusion criteria. A control group consisted of 36 healthy, age and sex-matched volunteers. RESULTS: The median Se concentration was 56.67 µg/L in the AIT group and 39.75 µg/L in the controls (p>0.05). Decreased Se concentration was observed in 62% of the patients and in 72% of the controls (p=0.47). There was no statistically significant difference in Se status in AIT group when compared to the other Polish, German, Austrian, Dutch and Greek populations with AIT. Significantly higher values were observed in Italian and Greek study when compared to present results in AIT group. CONCLUSIONS: No association between selenium status and prevalence of autoimmune thyroiditis in Polish population living in Poznan district was noticed. Nevertheless determination of the normal serum Se concentration for European populations is necessary. Further studies with enlarged studied groups should be implemented.
Assuntos
Selênio/sangue , Tireoidite Autoimune/sangue , Adulto , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Polônia , Prevalência , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/etiologia , Adulto JovemRESUMO
In women with chronic autoimmune thyroiditis and vitamin D deficiency we have found reference levels of relevant metabolic-hormonal parameters except for parathormone and total calcium. Three months supplementation with vitamin D (4300 IU/day, cholekalciferol) did not lead to significant changes of investigated hormonal parameters, while the levels of parathormone and calcium reached normal levels. However, a correlation analysis revealed marked changes in mutual relations. First, an inverse correlation of vitamin D with parathormone, insulin secretion (C peptide, insulin) and its efficiency (HOMA IR) disappeared. Relationships of vitamin D to hepatic insulin resistance (insulin/C peptide), to DHEA (both negative), and to DHEAS/DHEA ratio (positive) were newly found. Second, a positive correlation of CRP with insulin secretion remained, while its relation to insulin efficiency (HOMA IR, insulin/C peptide) was newly observed. Analogical positive correlations appeared also among anti TPO and insulinemia, insulin/C peptide, HOMA IR, and anti Tg to C peptide. A relationship of the CRP with anti TPO became significant (+). Third, out of glucose metabolism parameters only insulin/C peptide and glycemia did not correlate with vitamin D during its deficiency, while after supplementation insulin/C peptide alone correlated positively with both DHEAS and DHEA, and negatively with vitamin D.
Assuntos
Tireoidite Autoimune/sangue , Tireoidite Autoimune/tratamento farmacológico , Deficiência de Vitamina D/sangue , Deficiência de Vitamina D/tratamento farmacológico , Vitamina D/administração & dosagem , Vitamina D/sangue , Adulto , Glicemia/efeitos dos fármacos , Glicemia/metabolismo , Suplementos Nutricionais , Feminino , Humanos , Pessoa de Meia-Idade , Tireoidite Autoimune/epidemiologia , Deficiência de Vitamina D/epidemiologiaRESUMO
From the recent literature data it may be concluded that vitamin D deficiency is associated with increased risk of thyroid autoimmunity development and thus should be considered as an additional important risk factor for both chronic autoimmune thyroiditis (postpartum thyroiditis including) and Graves´ disease. A higher risk of Graves´ disease development is also associated with several polymorphisms in the gene encoding for vitamin D binding protein and for the specific receptor of active form of vitamin D - 1,25-(OH)2D3 in the respective target cells. Whether careful supplementation with vitamin D aimed to normalize low 25(OH)D levels brings preventive or therapeutic effect is subject to further research.Key words: autoimmune thyroiditis - D vitamin deficiency - D vitamin supplementation - Graves´disease.
Assuntos
Doença de Graves/epidemiologia , Tireoidite Autoimune/epidemiologia , Deficiência de Vitamina D/epidemiologia , Suplementos Nutricionais , Doença de Graves/metabolismo , Humanos , Polimorfismo Genético , Receptores de Calcitriol/genética , Tireoidite Autoimune/metabolismo , Vitamina D/análogos & derivados , Vitamina D/metabolismo , Vitamina D/uso terapêutico , Deficiência de Vitamina D/genética , Deficiência de Vitamina D/metabolismo , Proteína de Ligação a Vitamina D/genética , Vitaminas/uso terapêuticoRESUMO
CONTEXT: Epidemiological studies have supported the premise that an adequate selenium intake is essential for thyroid gland function. OBJECTIVE: The objective was to investigate whether the prevalence of thyroid disease differed in two areas that were similar, except for very different soil/crop selenium concentrations. DESIGN: Cross-sectional observational study. SETTING: The setting was two counties of Shaanxi Province, China, here defined as adequate- and low-selenium. PARTICIPANTS: A total of 6152 participants were selected by stratified cluster-sampling. MAIN OUTCOME MEASURES: Participants completed demographic and dietary questionnaires and underwent physical and thyroid ultrasound examinations. Serum samples were analyzed for thyroid function parameters and selenium concentration. Serum selenium was compared between different demographic, dietary, and lifestyle categories in the two counties. The relationship between selenium status, dietary factors, and pathological thyroid conditions was explored by logistic regression. RESULTS: Complete data sets were available from 3038 adequate-selenium participants and 3114 low-selenium participants in whom median (interquartile range) selenium concentrations differed almost 2-fold (103.6 [79.7, 135.9] vs 57.4 [39.4, 82.1] µg/L; P = .001). The prevalence of pathological thyroid conditions (hypothyroidism, subclinical hypothyroidism, autoimmune thyroiditis, and enlarged thyroid) was significantly lower in the adequate-selenium county than in the low-selenium county (18.0 vs 30.5%; P < .001). Higher serum selenium was associated with lower odds ratio (95% confidence interval) of autoimmune thyroiditis (0.47; 0.35, 0.65), subclinical hypothyroidism (0.68; 0.58, 0.93), hypothyroidism (0.75; 0.63, 0.90), and enlarged thyroid (0.75; 0.59, 0.97). CONCLUSIONS: Low selenium status is associated with increased risk of thyroid disease. Increased selenium intake may reduce the risk in areas of low selenium intake that exist not only in China but also in many other parts of the world.
Assuntos
Deficiências Nutricionais/fisiopatologia , Dieta/efeitos adversos , Hipotireoidismo/etiologia , Estado Nutricional , Selênio/deficiência , Glândula Tireoide/fisiopatologia , Tireoidite Autoimune/etiologia , Adolescente , Adulto , Idoso , China/epidemiologia , Produtos Agrícolas/química , Produtos Agrícolas/crescimento & desenvolvimento , Estudos Transversais , Deficiências Nutricionais/sangue , Deficiências Nutricionais/prevenção & controle , Feminino , Humanos , Hipotireoidismo/epidemiologia , Hipotireoidismo/fisiopatologia , Hipotireoidismo/prevenção & controle , Masculino , Pessoa de Meia-Idade , Tamanho do Órgão , Prevalência , Risco , Selênio/análise , Selênio/sangue , Selênio/uso terapêutico , Índice de Gravidade de Doença , Solo/química , Glândula Tireoide/patologia , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/fisiopatologia , Tireoidite Autoimune/prevenção & controle , Adulto JovemRESUMO
OBJECTIVE: Aberrations in maternal thyroid function and autoimmunity during pregnancy have been associated with negative obstetric outcome. In Denmark, a national iodine fortification program was implemented in the year 2000 with the aim to alleviate the mild-moderate iodine deficiency. Following the iodine implementation, there has been an increase in thyroid autoimmunity in the background population. This study investigates the thyroid status of pregnant Danish women following the iodine fortification program, and a possible association with preterm delivery. DESIGN: Historical cohort study of 1278 randomly selected pregnant Danish women attending the national Down's syndrome screening program. METHODS: The main outcome measures were thyroid status according to laboratory- and gestational-age-specific reference intervals, and association with risk of abnormal obstetric outcome. Antibody-positivity was defined as an antibody-level (thyroid peroxidase and/or thyroglobulin antibodies) above 60âU/ml. RESULTS: Establishing laboratory-specific gestational-age-dependent reference intervals, we found a prevalence of maternal thyroid dysfunction of 10%-15.8% by use of the cut-off suggested by the American Thyroid Association. Thyroid dysfunction was significantly associated with antibody-positivity (P<0.05). No associations were found between preterm delivery and thyroid dysfunction (adjusted OR 0.6, 95% CI: 0.1-2.3) or autoimmunity (adjusted OR 1.1, 95% CI: 0.4-2.7). CONCLUSIONS: After the implementation of the Danish iodine fortification program, the prevalence of thyroid dysfunction and autoimmunity in Danish pregnant women is high - even higher by use of pre-established reference intervals from international consensus guidelines. However, no associations were found with abnormal obstetric outcome. Large randomized controlled trials are needed to clarify the benefit of treating slight aberrations in pregnant women's thyroid function.
Assuntos
Autoanticorpos/imunologia , Alimentos Fortificados , Iodo , Complicações na Gravidez/epidemiologia , Nascimento Prematuro/epidemiologia , Doenças da Glândula Tireoide/epidemiologia , Adulto , Autoimunidade , Estudos de Coortes , Dinamarca/epidemiologia , Feminino , Idade Gestacional , Humanos , Hipertireoidismo/sangue , Hipertireoidismo/epidemiologia , Hipertireoidismo/imunologia , Hipotireoidismo/sangue , Hipotireoidismo/epidemiologia , Hipotireoidismo/imunologia , Iodeto Peroxidase/imunologia , Gravidez , Complicações na Gravidez/sangue , Complicações na Gravidez/imunologia , Prevalência , Doenças da Glândula Tireoide/sangue , Doenças da Glândula Tireoide/imunologia , Testes de Função Tireóidea , Tireoidite Autoimune/sangue , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/imunologia , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangueAssuntos
Antirreumáticos/efeitos adversos , Artrite Reumatoide/epidemiologia , Autoanticorpos/sangue , Terapia Biológica/efeitos adversos , Comorbidade , Doenças Reumáticas/tratamento farmacológico , Glândula Tireoide/efeitos dos fármacos , Tireoidite Autoimune/epidemiologia , Feminino , Humanos , MasculinoRESUMO
BACKGROUND: Since several countries have established mandatory food iodine fortification, there has been a decrease in rates of iodine deficiency disorders in parallel with an increase in prevalence of autoimmune thyroid diseases. This study compared the nutritional iodine status and the prevalence of autoimmune thyroiditis and thyroid hypoechogenicity on ultrasound in schoolchildren in São Paulo (Brazil) in two distinct periods of time in which fortified salt had different concentrations of iodine. METHODS: We conducted a cross-sectional study evaluating 206 children aged 7-14 years and without a history of thyroid disease. Assessments included measurements of thyrotropin (TSH), free thyroxine, antithyroperoxidase (anti-TPO), and antithyroglobulin (anti-TG) antibodies, urinary iodine concentration, and thyroid ultrasound. RESULTS: Mean urinary iodine concentration was 165.1 µg/L. Eleven children (5.3%) were diagnosed with autoimmune thyroiditis based on at least two of four criteria adopted in our study: positive anti-TPO or anti-TG antibody, hypoechogenicity of the thyroid parenchyma on ultrasound, and a TSH >4.0 µU/mL. Comparing our results with those from a similar study conducted during a period in which concentrations of iodine in the salt were higher (median urinary iodine concentration >300 µg/L), we observed a trend toward a lower prevalence of autoimmune thyroiditis, although no definitive conclusion could be established. CONCLUSION: The current nutritional iodine status in our cohort was within optimal levels and lower than levels found in 2003. The prevalence of autoimmune thyroiditis seems to be decreasing in parallel with a decrease in iodine intake, although we could not reach a definitive conclusion.
Assuntos
Alimentos Fortificados , Iodo , Glândula Tireoide/diagnóstico por imagem , Tireoidite Autoimune/epidemiologia , Adolescente , Autoanticorpos/sangue , Brasil/epidemiologia , Criança , Estudos Transversais , Feminino , Humanos , Masculino , Estado Nutricional , Prevalência , Tireoglobulina/imunologia , Tireoidite Autoimune/sangue , Tireoidite Autoimune/diagnóstico por imagem , Tireotropina/sangue , Tiroxina/sangue , UltrassonografiaRESUMO
Autoimmune thyroiditis (AIT) is one of the most common autoimmune diseases; genetic as well as environmental factors contribute to its pathogenesis. The thyroid is the organ with the highest selenium content per unit weight. Selenium status appears to have an impact on the development of thyroid pathologies. We investigated a possible difference of selenium serum levels as a marker of nutritional selenium supply between patients with AIT in central Lower Austria and a matched group of healthy persons living in the same region. Selenium serum levels in the patients with AIT were 98.0 ± 15.6 µg/l. A significant difference to the matched group of normal persons, whose selenium serum levels were 103.2 ± 12.4 µg/l, could not be detected by the t-test (p>0.05). We considered the serum selenium levels to be indicators of selenium supply (by alimentation). A serum level of 120-160 µg/l of selenium represents the normal range. According to this, most patients and control persons showed mild to moderate selenium deficiency (80-120 µg/l selenium). Although our data present slightly higher selenium levels in normal persons than in patients with AIT, this weak and statistically insignificant trend is not sufficient to support the conclusion of a link between inadequate selenium supply and autoimmune thyroid disease.
Assuntos
Selênio/sangue , Tireoidite Autoimune/sangue , Adulto , Áustria/epidemiologia , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Tireoidite Autoimune/epidemiologiaRESUMO
The prevalence of hyperthyroidism in women is between 0.5-2% and it is 10 times less common in men. The most common causes are Graves' disease, toxic multinodular goiter, and autonomously functioning thyroid adenoma. Rare causes of hyperthyroidisms are as follow: pituitary adenoma, autoimmune thyroiditis (Hashitoxicosis), levothyroxine overdose, inadequate iodine supplementation (including amiodaron induced hyperthyroidism, iodine-based contrast media), hCG excess (pregnancy, gestational trophoblastic disease, germ-cell tumors), drug induced hyperthyroidism, differentiated thyroid carcinomas and/or their metastases, struma ovarii, and familial nonautoimmune hyperthyroidism. This article focuses on the current data of etiopathogenesis of hyperthyroidisms. Genetic factors (like HLA-DR3,CD40, CTLA-4, PTPN22, FOXP3 CD25) and thyroid specific genes (thyroglobulin, TSHR, G(s)alpha) and environmental and endogenous factors (such as age, iodine, selenium, emotional stress, smoking, gender, pregnancy, sex hormones, fetal microchimerism, fetal growth, bacterial infections, viral infections, allergies, drugs (alemtuzumab, interferon alpha, iplimumab/tremelimumab, tyrosine kinase inhibitors, denileukindiftitox, thalidomide/lenalidomide, exposition to fallout and radiotherapy) have been described.
Assuntos
Hipertireoidismo/classificação , Hipertireoidismo/epidemiologia , Fatores Etários , Causalidade , Feminino , Bócio/epidemiologia , Doença de Graves/epidemiologia , Humanos , Hipersensibilidade/epidemiologia , Hipertireoidismo/genética , Infecções/epidemiologia , Masculino , Gravidez , Fatores de Risco , Distribuição por Sexo , Fumar/epidemiologia , Estresse Psicológico/epidemiologia , Neoplasias da Glândula Tireoide/epidemiologia , Tireoidite Autoimune/epidemiologiaRESUMO
AIM: The aim of the study was to evaluate the role of selenium (Se) in childhood autoimmune thyroiditis regarding its effect on thyroid-stimulating hormone (TSH), free thyroxine (fT4), thyroid peroxidase antibodies (TPOAb), thyroglobulin antibody (TgAb), and thyroid morphology. METHODS: Newly diagnosed 23 euthyroid children (mean age, 12.3 +/- 2.4 years) with Hashimoto thyroiditis (HT) received only 50 microg L-selenomethionine per day for 3 months. The baseline basal urinary iodine level, serum Se, TSH, fT4, TPOAb, and TgAb concentrations, and thyroid morphology by ultrasound were detected. We reanalyzed the TPOAb and TgAb changes at the 3rd month and then compared the thyroid morphology with 30 healthy individuals (mean age, 12.1 +/- 2.1 years) at the 6th month. RESULTS: Serum TPOAb, TgAb, and thyroid echogenicity were unchanged with Se supplementation. A prominent decrease in thyroid volume was noteworthy; 35% of patients showed a thyroid volume regression rate of > or = 30%. CONCLUSION: In terms of TPOAb and TgAb, Se may not benefit in the euthyroid period of HT, but Se supplementation seems to lead a favorable response in thyroid volume regression.
Assuntos
Selênio/administração & dosagem , Tireoidite Autoimune/tratamento farmacológico , Administração Oral , Adolescente , Idade de Início , Autoanticorpos/sangue , Criança , Feminino , Humanos , Masculino , Tamanho do Órgão/efeitos dos fármacos , Projetos Piloto , Selênio/sangue , Selênio/farmacologia , Testes de Função Tireóidea , Tireoidite Autoimune/sangue , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/patologia , Tireotropina/sangueRESUMO
PURPOSE: To investigate whether there is an increased incidence of chronic autoimmune thyroiditis (CAT) in individuals living in the vicinity of industrial plants that manufacture petroleum byproducts in the state of São Paulo, Brazil. METHODS: Between 1989 and 2004, 6,306 patients of both sexes, from 5 to 78 years old were divided in two groups according to their home location: Group 1: 3,356 residents living near industrial plants that manufacture petroleum byproducts (Region A), and Group 2: 2,950 residents living far from Region A in an area with predominantly steel industries (Region B). For all patients, we measured the serum levels of antithyroglobulin antibody, antithyroperoxidase antibody, triiodothyronine, thyroxine, free thyroxine and thyrostimulating hormone. Sonographic scans of the thyroid gland were also conducted. RESULTS: The proportion of patients with CAT coming from Region A increased from 2.5 % (5 patients with CAT/200 total patients) in 1992 to 57.6 % (106 patients with CAT/184 total patients) in 2001. This striking increase was highly significant (p < 0.001). Similar findings were not observed in Region B. The difference in the number of patients with CAT between 1989 and 2004 coming from Region A and Region B was highly significant (p < 0.001), with 905 CAT patients (83.95 %) in Region A and 173 CAT patients (16.05 %) in Region B. CONCLUSION: Our results showed a striking increase in the incidence of CAT in residents in the vicinity of large industrial plants that manufacture petroleum byproducts compared with residents living near steel industries, which opens the field to new areas of research.
Assuntos
Petróleo , Tireoidite Autoimune/epidemiologia , Adolescente , Adulto , Idoso , Autoanticorpos/sangue , Brasil/epidemiologia , Criança , Pré-Escolar , Feminino , Humanos , Incidência , Indústrias , Iodeto Peroxidase/imunologia , Masculino , Pessoa de Meia-Idade , Aço , Glândula Tireoide/diagnóstico por imagem , Tireoidite Autoimune/sangue , Tireoidite Autoimune/diagnóstico , Tireotropina/sangue , Tiroxina/sangue , Tri-Iodotironina/sangue , Ultrassonografia , Adulto JovemRESUMO
The endemic goiter, nutritional collective problem due to iodine deficience, constitutes a chronic disease with easy prevention and control, nevertheless still it constitutes a serious problem of public world health, being thought that about 650 million persons have goiter, 43 millions suffer from endemic cretinism and 1570 millions are in risk of suffering this disease for living in areas that present a deficit of iodine. Both patterns, deficit and the excess of iodine can conducted to a thyroid disease. The relation between the ingestion of iodine and the risk of disease corresponds to a U curve, where both, the low one and high ingestion of iodine it is associate to high risk of thyroid disease. To have a program of iodine supplementation, it should imply a constant vigilance of iodine nutrition to see its effect on the goiter prevalence in the population, to control his degree of fulfillment, to avoid a possible excess of ingestion of iodine it might help to correct any precocious alteration. Endemic goiter is not longer a problem in Chile. Salt iodination is in agreement with present legislation, but it is very important to have a continuous surveillance of iodine nutrition in Chile to control if salt fortification is appropiate.
Assuntos
Humanos , Criança , Bócio Endêmico/epidemiologia , Bócio Endêmico/prevenção & controle , Serviços de Saúde Escolar , Iodo/administração & dosagem , Bócio Endêmico/tratamento farmacológico , Chile , Deficiência de Iodo , América Latina , Distribuição por Sexo , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/induzido quimicamente , Iodo/urinaRESUMO
The role of vitamin D as an immune modulator has been emphasized in recent years, and low levels of the hormone were observed in several autoimmune diseases including multiple sclerosis and systemic lupus erythematosus. Vitamin D mediates its effect though binding to vitamin D receptor (VDR), and activation of VDR-responsive genes. While VDR gene polymorphism was found to associate with autoimmune thyroid diseases (AITDs), few studies examined levels of vitamin D in these patients and those that did yielded conflicting results. We therefore undertook to evaluate the levels of vitamin D in patients with AITDs compared to patients with non-AITDs and healthy controls. Serum vitamin D (25-OH) levels were measured in 50 patients with AITDs, 42 patients with non-AITDs and 98 healthy subjects, utilizing the LIAISON chemiluminescence immunoassay (DiaSorin, Saluggia, Italy). Vitamin D deficiency was designated at levels lower than 10 ng/ml. Antithyroid antibodies, thyroid functions and demographic parameters were evaluated in all patients. The prevalence of vitamin D deficiency was significantly higher in patients with AITDs compared with healthy individuals (72% versus 30.6%; P<0.001), as well as in patients with Hashimoto's thyroiditis compared to patients with non-AITDs (79% versus 52%; P<0.05). Vitamin D deficiency also correlated to the presence of antithyroid antibodies (P=0.01) and abnormal thyroid function tests (P=0.059). Significantly low levels of vitamin D were documented in patients with AITDs that were related to the presence of anti thyroid antibodies and abnormal thyroid function tests, suggesting the involvement of vitamin D in the pathogenesis of AITDs and the advisability of supplementation.
Assuntos
Autoanticorpos/metabolismo , Glândula Tireoide/metabolismo , Tireoidite Autoimune/imunologia , Deficiência de Vitamina D/imunologia , Vitamina D/sangue , Adulto , Autoanticorpos/imunologia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Prevalência , Estudos Retrospectivos , Testes de Função Tireóidea , Glândula Tireoide/imunologia , Glândula Tireoide/patologia , Tireoidite Autoimune/diagnóstico , Tireoidite Autoimune/epidemiologia , Tireoidite Autoimune/genética , Tireotropina/metabolismo , Vitamina D/imunologia , Deficiência de Vitamina D/diagnóstico , Deficiência de Vitamina D/epidemiologia , Deficiência de Vitamina D/genéticaRESUMO
The thyroid gland plays a major role in the human body; it produces the hormones necessary for appropriate energy levels and an active life. These hormones have a critical impact on early brain development and somatic growth. At the same time, the thyroid is highly vulnerable to autoimmune thyroid diseases (AITDs). They arise due to the complex interplay of genetic, environmental, and endogenous factors, and the specific combination is required to initiate thyroid autoimmunity. When the thyroid cell becomes the target of autoimmunity, it interacts with the immune system and appears to affect disease progression. It can produce different growth factors, adhesion molecules, and a large array of cytokines. Preventable environmental factors, including high iodine intake, selenium deficiency, and pollutants such as tobacco smoke, as well as infectious diseases and certain drugs, have been implicated in the development of AITDs in genetically predisposed individuals. The susceptibility of the thyroid to AITDs may come from the complexity of hormonal synthesis, peculiar oligoelement requirements, and specific capabilities of the thyroid cell's defense system. An improved understanding of this interplay could yield novel treatment pathways, some of which might be as simple as identifying the need to avoid smoking or to control the intake of some nutrients.
Assuntos
Doença de Graves/epidemiologia , Glândula Tireoide/imunologia , Tireoidite Autoimune/epidemiologia , Adolescente , Adulto , Idoso , Animais , Apresentação de Antígeno , Criança , Poluentes Ambientais/toxicidade , Predisposição Genética para Doença , Doença de Graves/genética , Doença de Graves/imunologia , Humanos , Lactente , Iodo/deficiência , Selênio/deficiência , Estresse Fisiológico , Tireoidite Autoimune/genética , Tireoidite Autoimune/imunologiaRESUMO
Autoimmune thyroiditis (AIT) is an autoimmune disease with genetic background. Women are more likely to develop AIT. In adulthood, AIT is the most frequent cause for acquired hypothyroidism. Cytotoxic T-lymphocyte antigen (CTL-4) may play a role in the etiology of the disease. Diagnosis is made by determination of elevated antibodies against thyroid peroxidase and thyroglobulin, and a hypoechoic pattern in ultrasound. In case of hypothyroidism a substitutive therapy with levothyroxine is necessary. AIT may occur as postpartum thyroiditis or as a special entity as consequence of therapy with cytokines.